Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
Sophie M ErnstSevim UzunMarthe S PaatsRonald van MarionPeggy N AtmodimedjoEvert de JongeRon H N van SchaikJoachim G J V AertsJan H von der ThüsenHendrikus Jan DubbinkAnne-Marie C DingemansPublished in: JCO precision oncology (2023)